Eric C. Wang

Eric C. Wang

Auto-generated profile, based on publicly available information

Eric C. Wang

Department of Chemistry

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 September 2025 in Organic Letters
Verified
Journal Article
Closed access
YZYiquan Zhao
Yiquan Zhao
EWEric C. Wang
Eric C. Wang
JPJinjae Park
Jinjae Park
ISIljin Shin
Iljin Shin
HKHyoungsu Kim
Hyoungsu Kim
JHJiyong Hong
Jiyong Hong

2 October 2025 in ACS Omega
Verified
Journal Article
Open access
EWEric C. Wang
Eric C. Wang
PJPyeonghwa Jeong
Pyeonghwa Jeong
CHChris Han
Chris Han
YOYunju Oh
Yunju Oh
YZYiquan Zhao
Yiquan Zhao
JHJiyong Hong
Jiyong Hong
The transient receptor potential vanilloid-1 (TRPV1) channel is a key mediator of pain perception and responds to various stimuli such as heat, low pH, and inflammation. Among TRPV1 antagonists, (R,E)-N-(2-hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)-phenyl)-acrylamide (AMG8562) shows promise as a nonopioid analgesic, attenuating pain behaviors in rodent models without eliciting hyperthermic side effects commonly associated with other TRPV1 antagonists. Despite its potential, there has been limited research regarding the synthesis of AMG8562. Here, we present an asymmetric synthesis of AMG8562 featuring a lipase-catalyzed kinetic resolution of racemic 4-nitroindan-2-ol. This approach enables scalable access to enantiomerically pure material and provides a platform for the synthesis of structurally diverse AMG8562 analogues with potential for improved pharmacological properties.